AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Natlimus 0.25mg Tablet

Prescription Icon
Prescription Required

Marketer

Natco Pharma Ltd

Salt Composition

Everolimus (0.25mg)

Overview Natlimus 0.25mg Tablet

Immunosuppressant tablets of Natlimus (0.25mg) prevent organ rejection following transplantation by modulating the immune system's response to the new organ. This medication also features in combination therapies for breast, pancreatic, lung, and kidney cancers. Adhere strictly to your physician's prescribed dosage and regimen for Natlimus 0.25mg Tablets. It can be administered with or without food, but maintaining consistent daily timing is crucial. An overdose can result in serious adverse effects. Common side effects include infections (respiratory and otherwise), fever, cough, fatigue, diarrhea, and respiratory tract irritation. Persistent or bothersome side effects warrant immediate medical attention. Report any allergic reactions (skin rashes, breathing difficulties, coughing, swelling) to your doctor immediately. Seek medical advice promptly if you experience excessive thirst, frequent urination, respiratory distress, fever, cough, or require vaccinations while using this medication. Prior to commencing treatment, disclose all existing medications and health conditions to your doctor. Pregnant or breastfeeding individuals should inform their physician before starting Natlimus. Regular blood tests may be recommended to monitor the medication's impact. As Natlimus may influence fertility in both men and women, discuss family planning with your doctor.

Uses of Natlimus 0.25mg Tablet

Preventing transplanted organ rejection

Major Benefits of Natlimus 0.25mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 0.25mg Natlimus tablet can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Natlimus 0.25mg Tablet:

  • Infection
  • Fever
  • Cough
  • Fatigue
  • Diarrhea
  • Upper respiratory tract infection

How to use Natlimus 0.25mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Natlimus 0.25mg Tablet can be consumed with or without food, though consistent timing is recommended for optimal results.

How Natlimus 0.25mg Tablet works:

Natlimus 0.25mg tablets modulate the body's immune response, thereby reducing the risk of organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Natlimus 0.25mg Tablets may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Natlimus 0.25mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Natlimus 0.25mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Natlimus 0.25mg Tablet, a medication that commonly causes fatigue. This fatigue is a potential side effect of Natlimus 0.25mg Tablet.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney impairment can safely use Natlimus 0.25mg tablets without requiring a dosage modification.

LiverLiverCAUTION

Patients with liver impairment should use Natlimus 0.25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Natlimus 0.25mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Natlimus 0.25mg Tablet :

NA

Facts to Know About Natlimus 0.25mg Tablet

LabelValue
Chemical Classification Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Therapeutics

FAQs on Natlimus 0.25mg Tablet

Close monitoring is necessary during Natlimus 0.25mg Tablet treatment. Your doctor will order blood tests to monitor red blood cell, white blood cell, and platelet counts (which may decrease), as well as kidney and liver function, blood glucose, and cholesterol levels.
Taking Natlimus 0.25mg Tablet with grapefruit or grapefruit juice can dangerously raise blood levels of the medication. Avoid grapefruit products and contact with individuals who have recently received live vaccines, or avoid live vaccines yourself.
Natlimus 0.25mg tablets may cause serious side effects, including life-threatening allergic reactions (like angioedema) and kidney failure. Respiratory problems and infections are also possible.
Natlimus 0.25mg tablets are a kinase inhibitor anticancer medication. They function by restricting tumor blood supply, thereby inhibiting cancer cell growth and metastasis.
Take Natlimus 0.25mg Tablet once or twice daily, consistently either with or without food. Swallow the tablet whole with water; do not crush or chew.
Treatment duration for Natlimus 0.25mg Tablet is variable, continuing until clinical improvement is observed or intolerable side effects develop.
Regular brain scans are necessary to monitor the effectiveness of Natlimus 0.25mg Tablet in reducing tumor size, as directed by your doctor and treatment plan.
Natlimus 0.25mg tablets exhibit cytotoxic activity against human cancer cells in breast, stomach, prostate, and kidney (renal cell carcinoma) tissues.
Natlimus 0.25mg Tablet
521
MRP 635
17% off